|
|
Volumn 27, Issue 1-2, 2008, Pages 19-41
|
|
T-cell-targeted signaling inhibitors
a
|
|
Author keywords
Autoimmune disease; Inflammatory disease; Signaling inhibitor; T cell; Transplant rejection
|
|
Indexed keywords
2 (6 AMINO 9 PURINYLMETHYL) 5 METHYL 3 (2 METHYLPHENYL) 3H QUINAZOLIN 4 ONE;
4 [N [1 (2 CYANO 1 OXOETHYL) 4 METHYL 3 PIPERIDINYL] N METHYLAMINO]PYRROLO[2,3 D]PYRIMIDINE;
5 (6 QUINOXALINYLMETHYLENE) 2,4 THIAZOLIDINEDIONE;
A 285222;
A 420983;
A 770041;
BMS 279700;
BMS 488516;
BMS 509744;
CALCINEURIN INHIBITOR;
CT 5652;
CYCLOSPORIN A;
FINGOLIMOD;
IC 8774;
ICI 8774;
IMMUNOMODULATING AGENT;
ISA 247;
JANUS KINASE 3;
NC 1153;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PNI 156804;
PROTEIN KINASE INHIBITOR;
PROTEIN KINASE ZAP 70;
PROTEIN TYROSINE KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
QUINAZOLINONE DERIVATIVE;
QUINOXALINE DERIVATIVE;
SPHINGOSINE 1 PHOSPHATE RECEPTOR;
T LYMPHOCYTE INHIBITOR;
TACROLIMUS;
TRANSCRIPTION FACTOR NFAT;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTIINFLAMMATORY ACTIVITY;
AUTOIMMUNE DISEASE;
B LYMPHOCYTE;
CYTOKINE PRODUCTION;
DIABETES MELLITUS;
DRUG BIOAVAILABILITY;
ENZYME INHIBITION;
GASTROINTESTINAL TOXICITY;
GRAFT REJECTION;
HUMAN;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER TOXICITY;
NEPHROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE ACTIVATION;
1-PHOSPHATIDYLINOSITOL 3-KINASE;
ANIMALS;
CALCINEURIN;
ENZYME INHIBITORS;
HUMANS;
JANUS KINASE 3;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK);
LYSOPHOSPHOLIPIDS;
NFATC TRANSCRIPTION FACTORS;
PROTEIN-TYROSINE KINASES;
RECEPTORS, ANTIGEN, T-CELL;
SIGNAL TRANSDUCTION;
SPHINGOSINE;
T-LYMPHOCYTE SUBSETS;
|
|
EID: 40049091607
PISSN: 08830185
EISSN: 15635244
Source Type: Journal
DOI: 10.1080/08830180701798976 Document Type: Review |
|
Times cited : (5)
|
|
References (98)
|
